Federal and State Cannabis Rules Are Moving in Different Directions – Diagnosing Health Care [PODCAST]
In this episode of the Diagnosing Health Care Podcast: Federal and state cannabis regulation and enforcement appear to be moving in different directions. While the Food and Drug Administration (“FDA”) has broadened its net to target businesses making claims that their products can treat specific conditions, a growing number of states have passed bills that, among other things, legalize adult-use cannabis.
Epstein Becker Green attorneys Delia Deschaine, Nathaniel Glasser, and Megan Robertson discuss how developments in 2021 impact the cannabis industry and why all players, including employers, health care providers and retailers, and businesses operating in the cannabis space, need to pay close attention to the different nuances between federal and state laws.
For more, listen to our previous episode on the FDA’s cannabis regulatory rulemaking:
Holding Pattern: Cannabis Industry Waits for FDA Regulatory Rulemaking